Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Glenn Gormley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- Ansbert Gadicke - $20.03M in AKTS purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $20.03M in AKTS purchases and sales in the last 12 months
- Helen Susan Kim - $15.03M in AKTS purchases and sales in the last 12 months
- Vida Ventures II, LLC - $15.03M in AKTS purchases and sales in the last 12 months
- Todd Foley - $4.19M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Glenn Gormley?
Glenn Gormley is a corporate insider of Aktis Oncology, Inc. (AKTS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Glenn Gormley last file a Form 4?
The only primary Form 4 on record is dated 16 April 2026.